General Announcement::Announcement by TMC Life Sciences Berhad - Redesignation of Acting GCEO to Non Executive Director

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$120M5.5%N280531 - SGXF52537366 - V2AB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
THOMSON MED S$160M4.65%N291029 - SGXF42557540 - 9BQB
THOMSON MED S$155M5.25%N270513 - SGXF30304939 - HUHB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
10-Feb-2025 17:53:58
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Berhad - Redesignation of Acting GCEO to Non Executive Director
Announcement Reference
SG250210OTHR4EX7
Submitted By (Co./ Ind. Name)
Dr Melvin Heng Jun Li
Designation
Executive Director and Group CEO
Description (Please provide a detailed description of the event in the box below)
The attached announcement was broadcast to Bursa Malaysia Securities Berhad on 10 February 2025.

Attachments

TMCLS Announcement - Redesignation of Acting GCEO to Non Independent and Non Executive Director.pdf
Total size =131K